BMY Stock Chart & Fundamental Analysis

Interactive Chart

About Bristol-Myers Squibb Company

Name

Bristol-Myers Squibb Company

CEO

Christopher S. Boerner

Website

www.bms.com

Industry

Healthcare

Year Founded

1887

Employees

34,100

Bristol-Myers Squibb Company (NYSE: BMY) develops, manufactures, and sells prescription medicines as a large biopharmaceutical company in healthcare. Across hematology, cancer, cardiovascular, immune, neurological, fibrotic, and infectious-disease treatment areas, it generated $48.2 billion of revenue in FY2025 through a portfolio that spans oncology, immunology, and cardiovascular therapies.

Analyst Ratings

Consensus Recommendation

Buy5

Hold2

Sell0

Fundamentals & Financials

Revenue (TTM)

$48.4B

Net Income (TTM)

$7.2B

EPS (TTM)

$3.56

ROA (TTM)

8.41%

Current Ratio

1.42

Dividend Yield

1.04%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$11,489M	$12,502M	$12,222M
Cost of Sales	$3,421M	$4,097M	$3,435M
Gross Profit	$8,068M	$8,405M	$8,787M
Operating Income	$3,271M	$1,419M	$3,639M
Net Income	$2,678M	$1,086M	$2,201M
EPS	$1.31	$0.53	$1.08

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Bristol-Myers Squibb Company's Technical Indicators Summary

Bristol-Myers Squibb displays a broadly constructive setup with price above most short- and medium-term moving averages and comfortably above the 200-day level, even as the 100-day is nearby. Momentum measures are mildly positive with CCI and a tepid MACD, while RSI sits in neutral territory and ADX indicates only a weak trend. Volatility is contained and ATR is moderate, and on-balance volume readings are mixed but not decisively negative. Technical takeaway: Strong Buy.

Buy

5 signals

Neutral

2 signals

Sell

0 signals

Overall: Bullish71% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	56.05	Neutral	RSI (56.05) is neutral.
Stochastic %K (14, 3, 3)	72.73	Neutral	Stochastic (72.73) is neutral.
CCI (20)	102.34	Buy	CCI (102.34) > 100, indicating strong upward momentum.
WPR (14)	-13.79	Sell	Williams %R (-13.79) > -20, indicating overbought.
Momentum (10)	2.85	Buy	Momentum (2.85) is positive.
MFI	48.10	Neutral	MFI (48.10) is neutral.
MACD Level (12, 26)	0.11	Buy	Confirmed uptrend: MACD (0.11) is positive and above its signal line (-0.21).
Bollinger Bands	$53.91 - $58.68	Neutral	Price is within the bands.
ATR (14)	$1.46 (2.51%)	Neutral	Moderate Volatility (2.51%).
ADX (14)	14.14	Neutral	Weak or consolidating trend (ADX < 25). ADX(14.14), +DI(26.22), -DI(20.44)
OBV	-64,453,674	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(-64,453,674), 20D-SMA-OBV(-71,684,340)
Classic Pivot Point	$56.81	Buy	Price ($58.13) has broken above resistance R1 ($57.33) — bullish breakout potential.
Fibonacci Pivot Point	$56.81	Buy	Price ($58.13) has broken above resistance R1 ($57.35) — bullish breakout potential.
Simple Moving Averages	$54.02 - $58.37(5 indicators)	Buy	SMA group: 4/5 bullish, 1 bearish, 0 neutral. Price above key SMA averages.
Exponential Moving Averages	$53.67 - $56.93(5 indicators)	Buy	EMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The day concluded with BMY retaining the 2.94% gap it started with from yesterday. By the close, sector strength was clear, with a 2.65% gain underpinning risk appetite. The day wrapped with modest participation in BMY, as overall volume reached only 0.36× average.

Trading Volume

vs S&P 500 Today

Outperforming Market

+1.99%

52-Week Position

Upper range

76.5%

Updated: July 2, 2026 at 20:05 UTC